Get Quote

Bruker Corp. (NASDAQ:BRKR)

CAPS Game Rating: 3 out of 5

The Company designs, manufactures, services and markets analytical and life science systems and associated products to address the needs of its customers in life science research, pharmaceutical, biotechnology and molecular diagnostics research.

Results 1 - 20 of 38 : 1 2 Next »

Recs

0
Member Avatar scrubs62074 (79.85) Submitted: 19/02/2013 16:00:53 : Outperform Start Price: $18.46 BRKR.US Score: -18.11

High Volume breakout on 02/19/13

Recs

0
Member Avatar 2008Rehab (54.83) Submitted: 03/01/2013 10:33:49 : Outperform Start Price: $16.23 BRKR.US Score: -11.04

Brkr 1-9, Brkr 1-9, 50% insider ownership. Gityer 20 in there.

Recs

0
Member Avatar OklaBoston (< 20) Submitted: 23/12/2012 04:08:00 : Outperform Start Price: $16.82 BRKR.US Score: -10.25

CEO Open market buying, a high rating from StockScouter, and some bullish charts, in basically that order.

Recs

0
Member Avatar Jonock (< 20) Submitted: 10/12/2012 12:28:41 : Outperform Start Price: $14.61 BRKR.US Score: -2.13

Future potential

Recs

0
Member Avatar Thorrider60 (< 20) Submitted: 13/08/2011 16:06:52 : Outperform Start Price: $14.53 BRKR.US Score: -24.58

Good growth over market..

Recs

0
Member Avatar milne005 (< 20) Submitted: 23/11/2010 15:44:02 : Outperform Start Price: $15.37 BRKR.US Score: -31.91

11/22/2010 IBD #96

Recs

0
Member Avatar kayceygirl (83.61) Submitted: 14/08/2010 01:29:08 : Outperform Start Price: $13.02 BRKR.US Score: -26.31

This is one of my STARZ.
Here is the thought process on this STAR:
a) Divided rate over Zero
b) 3 Year Beta between -5 & +3
c) 15% + Insider ownership
d) No greater than -50% Growth rate for the last 3 years (tought= last couple of years so goo that insiders are still owning the stocks)
e) Current CAPS rating between 3 Stars & 5 Stars
Open to all Industries and Sectors screened this down to just 250 stocks. I like round numbers. 12 of them I already own through other screening tools. I tend to be somewhat conservative but looking for 3 things at this point in my investing:
1. Stability & Strength
2. Yield and Modest Growth
3. Strong Position within a sector regardless of whether the entire sector is strong or not. Each sector has to perform to some degree for the whole world economy to function. I am looking for 5 or more years down the road, ROI, and Growth.
Not looking for rockets, just stars. This is a Star!!

Recs

0
Member Avatar GreatStocks3728 (< 20) Submitted: 23/05/2010 11:59:53 : Outperform Start Price: $12.54 BRKR.US Score: -20.02

Good growth and earnings ahead.

Recs

0
Member Avatar augustspillers (< 20) Submitted: 07/02/2010 13:31:30 : Outperform Start Price: $12.89 BRKR.US Score: -26.22

An outstanding R&D program; partnered with many international companies; on the leading edge of development in several product areas.

Recs

0
Member Avatar skipaha (30.47) Submitted: 12/07/2009 01:34:00 : Outperform Start Price: $8.18 BRKR.US Score: +15.19

Bounced back down from its recent run. At PE of 18, this looks solid.

Recs

0
Member Avatar JohanHansen (75.63) Submitted: 20/06/2009 14:35:35 : Outperform Start Price: $8.75 BRKR.US Score: +7.70

T2 PB2

Recs

0
Member Avatar at38lantis (< 20) Submitted: 29/05/2009 13:00:27 : Outperform Start Price: $6.50 BRKR.US Score: +73.31

Continued development of superb products and outstanding marketing along with joint development agreements will help PUSH Bruker

Recs

1
Member Avatar happypapy (< 20) Submitted: 19/04/2009 10:40:14 : Outperform Start Price: $6.85 BRKR.US Score: +47.77

Award winning analytical equipment manufacturer. Pioneer and leader in solid EDX products. Top engineering management team. Significant and continuing management stock buy in shows confidence. Excellent earnings forecast. Acquiring successful compatible companies as well as focused internal growth.

Recs

1
Member Avatar Trimalerus (88.53) Submitted: 23/03/2009 18:41:09 : Outperform Start Price: $5.49 BRKR.US Score: +98.02

The fact that stem cell research is now again legal in the US is encouraging. And I saw on the scorecard that other members have outperformed with this stock even above $7.00 so it looks like a good time to buy & hold this stock.

Recs

1
Member Avatar traderpat9 (75.35) Submitted: 15/01/2009 00:27:07 : Outperform Start Price: $4.47 BRKR.US Score: +173.42

THIS IS A VERY INTERESTING STOCK. I AM GOING TO WATCH THIS ONE CAREFULLY & LET YOU KNOW WHEN I AM GOING TO JUMP IN. HAS TAKEN A DRASTIC BEATING UNDERPERFORMING THE S&P

Recs

0
Member Avatar nycgrip (< 20) Submitted: 09/01/2009 02:34:23 : Outperform Start Price: $4.11 BRKR.US Score: +221.90

in at 4.15, my amateur analysis says this stock belongs between 7.5-10 within next 2 years if not 1.

Recs

0
Member Avatar ken49620 (91.12) Submitted: 31/12/2008 16:56:58 : Outperform Start Price: $4.10 BRKR.US Score: +221.43

I bought in on BRKR, ROE is good.

Recs

0
Member Avatar RockyNicky3728S (47.39) Submitted: 25/12/2008 15:41:52 : Outperform Start Price: $4.19 BRKR.US Score: +205.75

Good growth and future earnings.

Recs

0
Member Avatar NoDoughBro (69.73) Submitted: 04/11/2008 11:22:25 : Outperform Start Price: $5.57 BRKR.US Score: +130.50

Obama = Healthcare

Recs

0
Member Avatar jatava (75.72) Submitted: 22/07/2008 23:12:04 : Outperform Start Price: $12.13 BRKR.US Score: +15.49

10.000

Results 1 - 20 of 38 : 1 2 Next »

For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.